Compared with corresponding normal samples, higher NT5DC2 expression was observed in stomach adenocarcinoma (STAD), thymoma (THYM) et al (Fig. 2C), which were consistent with trend of NT5DC2 expression in metastatic GC. This evidence concerns the gene NT5DC2 and gastric cancer.